Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV-1 Tat is present in the serum of people living with HIV-1 despite viral suppression.
Shmakova A, Tsimailo I, Kozhevnikova Y, Gérard L, Boutboul D, Oksenhendler E, Tuaillon E, Rivault A, Germini D, Vassetzky Y, Beaumelle B. Shmakova A, et al. Among authors: boutboul d. Int J Infect Dis. 2024 May;142:106994. doi: 10.1016/j.ijid.2024.106994. Epub 2024 Mar 4. Int J Infect Dis. 2024. PMID: 38447753 Free article.
Chronic HIV-1 Tat action induces HLA-DR downregulation in B cells: A mechanism for lymphoma immune escape in people living with HIV.
Shmakova A, Hugot C, Kozhevnikova Y, Schwager Karpukhina A, Tsimailo I, Gérard L, Boutboul D, Oksenhendler E, Szewczyk-Roszczenko O, Roszczenko P, Buzun K, Sheval EV, Germini D, Vassetzky Y. Shmakova A, et al. Among authors: boutboul d. J Med Virol. 2024 Feb;96(2):e29423. doi: 10.1002/jmv.29423. J Med Virol. 2024. PMID: 38285479
HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells.
Germini D, Tsfasman T, Klibi M, El-Amine R, Pichugin A, Iarovaia OV, Bilhou-Nabera C, Subra F, Bou Saada Y, Sukhanova A, Boutboul D, Raphaël M, Wiels J, Razin SV, Bury-Moné S, Oksenhendler E, Lipinski M, Vassetzky YS. Germini D, et al. Among authors: boutboul d. Leukemia. 2017 Nov;31(11):2515-2522. doi: 10.1038/leu.2017.106. Epub 2017 Mar 31. Leukemia. 2017. PMID: 28360415
Reply to Rokx et al.
Le Joncour A, Bidegain F, Ziol M, Nebbad B, Galicier L, Oksenhendler E, Mechai F, Boutboul D, Bouchaud O. Le Joncour A, et al. Among authors: boutboul d. Clin Infect Dis. 2016 Aug 1;63(3):428. doi: 10.1093/cid/ciw304. Epub 2016 May 8. Clin Infect Dis. 2016. PMID: 27161782 No abstract available.
Hodgkin Lymphoma-related Inflammatory Modification-displayed Castleman Disease-like Histological Features and Positron Emission Tomography/Computed Tomography Usefulness for the Differential Diagnosis.
Yamauchi H, Momoki M, Kamiyama Y, Gunji T, Yokoyama H, Saito T, Boutboul D, Oksenhendler E, Yano S. Yamauchi H, et al. Among authors: boutboul d. Intern Med. 2024 Apr 1;63(7):993-998. doi: 10.2169/internalmedicine.2284-23. Epub 2023 Aug 9. Intern Med. 2024. PMID: 37558474 Free PMC article.
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia.
Sorin B, Fadlallah J, Garzaro M, Vigneron J, Bertinchamp R, Boutboul D, Oksenhendler E, Fieschi C, Malphettes M, Galicier L. Sorin B, et al. Among authors: boutboul d. Ann Hematol. 2023 Aug;102(8):2059-2068. doi: 10.1007/s00277-023-05340-0. Epub 2023 Jun 29. Ann Hematol. 2023. PMID: 37386347
Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor.
Gouilleux-Gruart V, Chapel H, Chevret S, Lucas M, Malphettes M, Fieschi C, Patel S, Boutboul D, Marson MN, Gérard L, Lee M, Watier H, Oksenhendler E; DEFI study group. Gouilleux-Gruart V, et al. Among authors: boutboul d. Clin Exp Immunol. 2013 Feb;171(2):186-94. doi: 10.1111/cei.12002. Clin Exp Immunol. 2013. PMID: 23286945 Free PMC article.
141 results